Lv0
0 积分 2024-06-29 加入
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
10天前
已完结
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
10天前
已完结
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease
10天前
已完结
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
10天前
已完结
Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic AnginaA Randomized Controlled Trial
22天前
已完结
Safety and pharmacokinetics of bapineuzumab in a single ascending‐dose study in Japanese patients with mild to moderate Alzheimer's disease
23天前
已完结
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
23天前
已完结
Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine
29天前
已完结
Platelet indexes in relation to target organ damage in high-risk hypertensive patients
29天前
已完结
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
1个月前
已完结
皖公网安备34019202002308
